CASE PRESENTATION ON VITAMIN D DEFICIENCY-INDUCED FATTY LIVER DISEASE IN A 36-YEAR-OLD MALE
DOI:
https://doi.org/10.22159/ajpcr.2025v18i7.54540Keywords:
Vitamin D deficiency,, Non-alcoholic fatty liver disease, Hepatic steatosis, Sedentary lifestyleAbstract
Vitamin D deficiency has emerged as a significant contributing factor to the development of non-alcoholic fatty liver disease (NAFLD), a prevalent condition associated with metabolic dysfunction. This case presentation focuses on a 36-year-old male patient diagnosed with NAFLD likely induced by vitamin D deficiency. The patient presented with symptoms of fatigue, right upper quadrant abdominal discomfort, and unexplained weight gain over the past year. Laboratory tests revealed elevated liver enzymes and a severely low vitamin D level of 12 ng/mL. Imaging studies, including abdominal ultrasound, confirmed mild hepatic steatosis with grade 2 fatty liver. The patient’s history of limited sun exposure and sedentary lifestyle were contributing factors to the deficiency. Management included vitamin D supplementation, dietary changes, and regular physical activity. This case emphasizes the role of vitamin D deficiency in the pathogenesis of NAFLD and underscores the importance of addressing this deficiency as part of a comprehensive treatment plan for improving liver health and preventing further progression.
Downloads
References
Warman NB, Shah FZ, Mohamad AF, Zainordin NA, Awang MH, Koshy M, et al. Vitamin D deficiency in patients with non-alcoholic fatty liver disease and type 2 diabetes mellitus. J ASEAN Fed Endocr Soc. 2024;39 Suppl 1:10. doi: 10.15605/jafes.039.S1.010
Kumar M, Parchani A, Kant R, Das A. Relationship between vitamin D deficiency and non-alcoholic fatty liver disease: A cross-sectional study from a tertiary care center in Northern India. Cureus. 2023;15(2):e34921. doi: 10.7759/cureus.34921, PMID 36938188
Permatasari D, Aini N, Yosmar R. Effects of post-chemotherapy drugs on the liver function tests in pediatric patients with acute lymphoblastic leukemia (all). Int J Appl Pharm. 2025;17(1):61-6. doi: 10.22159/ ijap.2025.v17s1.09
Musso G, Gambino R, Cassader M, Pagano G. The role of vitamin D in nonalcoholic fatty liver disease: Mechanisms and therapeutic implications. Curr Diabetes Rep. 2010;10(2):135-41. doi: 10.1007/ s11892-010-0120-0
Rosyid FN, Haryoto O, Kristinawati B, Rahman AF. The effect of supplementation of capsule with a combination of Momordica charantia fruit and Moringa oleifera leaves extract on the biomarker of liver and renal function in the limited healthy volunteers. Int J Appl Pharm. 2024;16(5):114-7. doi: 10.22159/ijap.2024v16s5.52468
Hsia SH, Gattu S. Vitamin D and fatty liver disease: A review of the literature. J Clin Med. 2018;7(12):486. doi: 10.3390/jcm7120486
Muthusamy S, Chidambaram M. Vitamin D deficiency and nonalcoholic fatty liver disease. J Clin Transl Hepatol. 2015;3(3):148-53. doi: 10.14218/JCTH.2015.00009
Laird E, Campbell M. Vitamin D and its role in nonalcoholic fatty liver disease. World J Hepatol. 2015;7(2):262-8. doi: 10.4254/wjh.v7.i2.262
Weng SW, Chou CK, Wang WH. Association between vitamin D and fatty liver disease: A review of clinical studies. J Nutr Biochem. 2018;62:1-8. doi: 10.1016/j.jnutbio.2018.01.010
Published
How to Cite
Issue
Section
Copyright (c) 2025 Sreenu Thalla, Dr R Kamraj, Dr A Kavitha

This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.